跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG - HSA Drug Approval Details
Approvals
/
HSA
/
ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG
Approved
STANDARD
ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
57cf00107564d997
Company
Unknown
Type
Standard
Approval Details
Approval Id
57cf00107564d997
Drug Name
ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG
Active Ingredients
Lamivudine
300.000 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
57cf00107564d997
Type
Standard
Back to HSA Approvals
